- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/36 - One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Patent holdings for IPC class C07D 239/36
Total number of patents in this class: 260
10-year publication summary
|
25
|
26
|
22
|
14
|
21
|
20
|
17
|
11
|
9
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 517 |
21 |
| Celgene Quanticel Research, Inc. | 167 |
13 |
| Takeda Pharmaceutical Company Limited | 2945 |
10 |
| Sunshine Lake Pharma Co., Ltd. | 567 |
8 |
| Merck Sharp & Dohme Corp. | 2218 |
7 |
| z Factor Limited | 19 |
7 |
| Glenmark Pharmaceuticals S.A. | 120 |
6 |
| Neurocrine Biosciences, Inc. | 399 |
6 |
| Novartis AG | 11297 |
5 |
| Glaxo Group Limited | 4286 |
4 |
| F. Hoffmann-La Roche AG | 7942 |
4 |
| ASKA Pharmaceutical Co., Ltd. | 105 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 803 |
4 |
| Bristol-myers Squibb Company | 4886 |
3 |
| Hoffmann-La Roche Inc. | 3252 |
3 |
| Merck Patent GmbH | 5849 |
3 |
| Bayer Cropscience AG | 2143 |
3 |
| ADAMA Makhteshim Ltd. | 467 |
3 |
| Atrogi AB | 52 |
3 |
| National Institute of Biological Sciences, Beijing | 94 |
3 |
| Other owners | 140 |